May 19, 2016
Boston, MA
Patent practice in the life sciences is constantly evolving. New USPTO Guidance on 35 U.S.C. § 101 has been issued. The Federal Circuit has continued to face a plethora of issues that go to the very heart of our patent system, including basic questions, such as when subject matter is patentable, what the presumptions are in deciding validity, and even the appropriate standards of review from the Patent Trial and Appeal Board (PTAB) and district court proceedings. The PTAB, while initially slow to start with respect to pharmaceutical and biotechnology proceedings, has gained momentum. There are now a number of significant decisions in this area, and new rules were recently issued that may significantly change IPR practice. While much of the attention has focused on post-grant challenges, pre-grant challenges offer an important option in evaluating your competitor’s patent portfolio. Please join us as we address these issues and provide insight to help guide your practice, including on:
Due to space limitation, please register early.
Speakers:
Howard W. Levine
Jill K. MacAlpine, Ph.D.
Leslie A. McDonell
Amanda K. Murphy, Ph.D.
Sanya Sukduang
Date:
Thursday, May 19, 2016
Time:
1:30 - 2:00 p.m. – Registration
2:00 - 5:15 p.m. – Workshop
5:15 - 6:30 p.m. – Reception
Location:
Finnegan
Two Seaport Lane
Boston, MA 02210
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.